Immunome
IMNM
IMNM
35 hedge funds and large institutions have $15.4M invested in Immunome in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.73% more ownership
Funds ownership: 15.22% → 15.95% (+0.73%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
35
Holding in Top 10
–
Calls
$312K
Puts
$263K
Top Buyers
| 1 | +$3.31M | |
| 2 | +$123K | |
| 3 | +$109K | |
| 4 |
HBCM
Heron Bay Capital Management
Bloomfield Hills,
Michigan
|
+$104K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$81.5K |
Top Sellers
| 1 | -$2.53M | |
| 2 | -$662K | |
| 3 | -$14.6K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$7.97K |
| 5 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
-$1.19K |